» Articles » PMID: 7902575

Conversion of Alpha-helices into Beta-sheets Features in the Formation of the Scrapie Prion Proteins

Overview
Specialty Science
Date 1993 Dec 1
PMID 7902575
Citations 675
Authors
Affiliations
Soon will be listed here.
Abstract

Prions are composed largely, if not entirely, of prion protein (PrPSc in the case of scrapie). Although the formation of PrPSc from the cellular prion protein (PrPC) is a post-translational process, no candidate chemical modification was identified, suggesting that a conformational change features in PrPSc synthesis. To assess this possibility, we purified both PrPC and PrPSc by using nondenaturing procedures and determined the secondary structure of each. Fourier-transform infrared (FTIR) spectroscopy demonstrated that PrPC has a high alpha-helix content (42%) and no beta-sheet (3%), findings that were confirmed by circular dichroism measurements. In contrast, the beta-sheet content of PrPSc was 43% and the alpha-helix 30% as measured by FTIR. As determined in earlier studies, N-terminally truncated PrPSc derived by limited proteolysis, designated PrP 27-30, has an even higher beta-sheet content (54%) and a lower alpha-helix content (21%). Neither PrPC nor PrPSc formed aggregates detectable by electron microscopy, while PrP 27-30 polymerized into rod-shaped amyloids. While the foregoing findings argue that the conversion of alpha-helices into beta-sheets underlies the formation of PrPSc, we cannot eliminate the possibility that an undetected chemical modification of a small fraction of PrPSc initiates this process. Since PrPSc seems to be the only component of the "infectious" prion particle, it is likely that this conformational transition is a fundamental event in the propagation of prions.

Citing Articles

Prion propensity of Betacoronaviruses including SARS-CoV-2.

Haddad H, Al-Zyoud W Heliyon. 2025; 11(4):e42199.

PMID: 40034268 PMC: 11874563. DOI: 10.1016/j.heliyon.2025.e42199.


Prion Protein Endoproteolysis: Cleavage Sites, Mechanisms and Connections to Prion Disease.

Castle A, Westaway D J Neurochem. 2025; 169(1):e16310.

PMID: 39874431 PMC: 11774512. DOI: 10.1111/jnc.16310.


Emerging perspectives of copper-mediated transcriptional regulation in mammalian cell development.

Fitisemanu F, Padilla-Benavides T Metallomics. 2024; 16(10).

PMID: 39375833 PMC: 11503025. DOI: 10.1093/mtomcs/mfae046.


A Systematic Review of Sporadic Creutzfeldt-Jakob Disease: Pathogenesis, Diagnosis, and Therapeutic Attempts.

Jurcau M, Jurcau A, Diaconu R, Hogea V, Nunkoo V Neurol Int. 2024; 16(5):1039-1065.

PMID: 39311352 PMC: 11417857. DOI: 10.3390/neurolint16050079.


Single-domain antibodies and aptamers drive new opportunities for neurodegenerative disease research.

Shoemaker R, Larsen R, Larsen P Front Immunol. 2024; 15:1426656.

PMID: 39238639 PMC: 11374656. DOI: 10.3389/fimmu.2024.1426656.


References
1.
JARRETT J, Lansbury Jr P . Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie?. Cell. 1993; 73(6):1055-8. DOI: 10.1016/0092-8674(93)90635-4. View

2.
Scott M, Groth D, Foster D, Torchia M, Yang S, DeArmond S . Propagation of prions with artificial properties in transgenic mice expressing chimeric PrP genes. Cell. 1993; 73(5):979-88. DOI: 10.1016/0092-8674(93)90275-u. View

3.
Bueler H, Aguzzi A, Sailer A, Greiner R, Autenried P, Aguet M . Mice devoid of PrP are resistant to scrapie. Cell. 1993; 73(7):1339-47. DOI: 10.1016/0092-8674(93)90360-3. View

4.
Come J, Fraser P, Lansbury Jr P . A kinetic model for amyloid formation in the prion diseases: importance of seeding. Proc Natl Acad Sci U S A. 1993; 90(13):5959-63. PMC: 46846. DOI: 10.1073/pnas.90.13.5959. View

5.
DeArmond S, Yang S, Lee A, Bowler R, Taraboulos A, Groth D . Three scrapie prion isolates exhibit different accumulation patterns of the prion protein scrapie isoform. Proc Natl Acad Sci U S A. 1993; 90(14):6449-53. PMC: 46949. DOI: 10.1073/pnas.90.14.6449. View